770 related articles for article (PubMed ID: 27565734)
1. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulated Pomegranate Reverts High-Density Lipoprotein (HDL)-Induced Endothelial Dysfunction and Reduces Postprandial Triglyceridemia in Women with Acute Coronary Syndrome.
Estrada-Luna D; Carreón-Torres E; Bautista-Pérez R; Betanzos-Cabrera G; Dorantes-Morales A; Luna-Luna M; Vargas-Barrón J; Mejía AM; Fragoso JM; Carvajal-Aguilera K; García-Trejo JJ; Vargas-Alarcón G; Pérez-Méndez Ó
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349559
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of linagliptin and voglibose on endothelial function in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, pilot study (EFFORT).
Koyama T; Tanaka A; Yoshida H; Oyama JI; Toyoda S; Sakuma M; Inoue T; Otsuka Y; Node K
Heart Vessels; 2018 Aug; 33(8):958-964. PubMed ID: 29427024
[TBL] [Abstract][Full Text] [Related]
4. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.
Zhao SP; Liu L; Cheng YC; Shishehbor MH; Liu MH; Peng DQ; Li YL
Circulation; 2004 Aug; 110(8):915-20. PubMed ID: 15313947
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study.
Ohno Y; Miyoshi T; Noda Y; Oe H; Toh N; Nakamura K; Kohno K; Morita H; Ito H
Cardiovasc Diabetol; 2014 Apr; 13():71. PubMed ID: 24708775
[TBL] [Abstract][Full Text] [Related]
6. Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease.
Sawada T; Uzu K; Hashimoto N; Onishi T; Takaya T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H
J Atheroscler Thromb; 2020 Jul; 27(7):644-656. PubMed ID: 31631099
[TBL] [Abstract][Full Text] [Related]
7. Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease.
Emoto T; Sawada T; Hashimoto M; Kageyama H; Terashita D; Mizoguchi T; Mizuguchi T; Motodi Y; Iwasaki M; Taira K; Okamoto H; Matsuo Y; Kim SK; Takarada A; Yokoyama M
Am J Cardiol; 2012 Jan; 109(1):42-6. PubMed ID: 21944671
[TBL] [Abstract][Full Text] [Related]
8. Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease.
Toyama K; Nishioka T; Isshiki A; Ando T; Inoue Y; Kirimura M; Kamiyama T; Sasaki O; Ito H; Maruyama Y; Yoshimoto N
Cardiovasc Drugs Ther; 2014 Feb; 28(1):53-9. PubMed ID: 24158248
[TBL] [Abstract][Full Text] [Related]
9. The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy.
Tani S; Nagao K; Kawauchi K; Yagi T; Atsumi W; Matsuo R; Hirayama A
Am J Cardiovasc Drugs; 2017 Oct; 17(5):409-420. PubMed ID: 28634822
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
Warnholtz A; Wild P; Ostad MA; Elsner V; Stieber F; Schinzel R; Walter U; Peetz D; Lackner K; Blankenberg S; Munzel T
Atherosclerosis; 2009 May; 204(1):216-21. PubMed ID: 18822413
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and chronic attenuation of postprandial hyperglycemia on postglucose-load endothelial function in insulin resistant individuals: is stimulation of first phase insulin secretion beneficial for the endothelial function?
Major-Pedersen A; Ihlemann N; Hermann TS; Christiansen B; Kveiborg B; Dominguez H; Nielsen D; Rask-Madsen C; Svendsen OL; Køber L; Torp-Pedersen C
Horm Metab Res; 2008 Sep; 40(9):607-13. PubMed ID: 18792871
[TBL] [Abstract][Full Text] [Related]
12. Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.
Tripolt NJ; Aberer F; Riedl R; Url J; Dimsity G; Meinitzer A; Stojakovic T; Aziz F; Hödl R; Brachtl G; Strunk D; Brodmann M; Hafner F; Sourij H
Cardiovasc Diabetol; 2018 May; 17(1):71. PubMed ID: 29773079
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease.
Nakamura A; Monma Y; Kajitani S; Noda K; Nakajima S; Endo H; Takahashi T; Nozaki E
Heart Vessels; 2016 Sep; 31(9):1446-55. PubMed ID: 26439243
[TBL] [Abstract][Full Text] [Related]
14. Impact of postprandial hypertriglyceridemia on vascular responses in patients with coronary artery disease: effects of ACE inhibitors and fibrates.
Bae JH; Bassenge E; Lee HJ; Park KR; Park CG; Park KY; Lee MS; Schwemmer M
Atherosclerosis; 2001 Sep; 158(1):165-71. PubMed ID: 11500188
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.
Yunoki K; Nakamura K; Miyoshi T; Enko K; Kohno K; Morita H; Kusano KF; Ito H
Atherosclerosis; 2011 Aug; 217(2):486-91. PubMed ID: 21592480
[TBL] [Abstract][Full Text] [Related]
16. Predictors of endothelial function improvement in patients with mild hypertriglyceridemia without evidence of coronary artery disease treated with purified eicosapentaenoic acid.
Fukumoto K; Takemoto Y; Yoshikawa J; Norioka N; Iguchi T; Namikawa H; Tochino Y; Yoshiyama M; Shuto T
Atherosclerosis; 2020 Sep; 309():27-32. PubMed ID: 32861211
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects.
Nagashima H; Endo M
Heart Vessels; 2011 Jul; 26(4):428-34. PubMed ID: 21132308
[TBL] [Abstract][Full Text] [Related]
18. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.
Derosa G; Cicero AF; Fogari E; D'Angelo A; Bonaventura A; Romano D; Maffioli P
J Clin Lipidol; 2012; 6(6):553-64. PubMed ID: 23312051
[TBL] [Abstract][Full Text] [Related]
19. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study.
Budoff M; Brent Muhlestein J; Le VT; May HT; Roy S; Nelson JR
Clin Cardiol; 2018 Jan; 41(1):13-19. PubMed ID: 29365351
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment.
Ceriello A; Taboga C; Tonutti L; Quagliaro L; Piconi L; Bais B; Da Ros R; Motz E
Circulation; 2002 Sep; 106(10):1211-8. PubMed ID: 12208795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
